The IDH1-R132H mutation is involved in the early gliomagenesis; however, after carcinogenesis complete, it is considered a radiosensitizing gene and a better prognostic factor that predicts favorable outcome in glioma patients (3, 33–35). Here, IDH1 is linked to central nervous system cancer.